Table 3. A comparison of laboratory investigations of the study sample.
BMI: body mass index, TC: total cholesterol, TGL: triglycerides, HDL: high-density lipoprotein, LDL: low-density lipoprotein, FBG: fasting blood glucose, HbA1c: glycated hemoglobin A1c, N: number of subjects, DM: diabetes mellitus.
p-value <0.05 was considered significant.
| DM with neuropathy, N = 100 | DM without neuropathy, N = 100 | Total, N = 200 (%) | p-value | ||
| BMI (kg/m2) | 18-24.99 | 36 | 45 | 81 (40.5) | 0.195 |
| ≥25 | 64 | 55 | 119 (59.5) | ||
| TC (mg/dL) | ≤200 | 41 | 46 | 87 (43.5) | 0.476 |
| >200 | 59 | 54 | 113 (56.5) | ||
| TGL (mg/dL) | ≤150 | 44 | 44 | 88 (44) | 1 |
| >150 | 56 | 56 | 112 (56) | ||
| HDL (mg/dL) | ≤35 | 60 | 70 | 130 (62) | 0.138 |
| >35 | 40 | 30 | 70 (35) | ||
| LDL (mg/dL) | ≤135 | 40 | 39 | 79 (39.5) | 0.885 |
| >135 | 60 | 61 | 121 (60.5) | ||
| FBG (mg/dL) | ≤140 | 20 | 53 | 73 (36.5) | 0.001 |
| >140 | 80 | 47 | 127 (63.5) | ||
| HbA1c (%) | ≤6.5 | 24 | 55 | 79 (39.5) | 0.001 |
| >6.5 | 76 | 45 | 121 (60.5) | ||
| B12 (pg/mL) | >200 | 37 | 40 | 77 (38.5) | 0.663 |
| ≤200 | 63 | 60 | 123 (61.5) | ||